文献速递牙周病牙体牙髓病

PGE2调控牙再植后牙周膜修复的机制研究

PGE2 Regulates Periodontal Ligament Repair after Tooth Replantation.
PubMed 文献 · J Dent Res · 2026-02-11

本研究探讨牙再植后前列腺素E2(PGE2)对牙周膜干细胞(hPDLSCs)及牙周膜修复的影响。小鼠模型显示再植后1-3天环氧合酶-2和PGE2升高;体外实验表明PGE2及EP4激动剂通过上调TCIM激活Wnt/β-catenin通路促进hPDLSCs增殖。体内给予SW033291或L-902688可改善再植结局并增加TCIM表达,提示PGE2/EP4/TCIM轴是潜在药物靶点。

要点

  • 牙再植后牙周膜内PGE2在1-3天内短暂升高
  • PGE2通过EP4受体促进hPDLSCs增殖与活力
  • TCIM是PGE2促增殖的关键下游靶点

核心结论

  • 牙再植后PGE2短暂升高,通过EP4激活上调TCIM并激活Wnt通路,增强hPDLSCs增殖能力,促进牙周膜修复。

研究设计与样本

  • 建立小鼠牙再植模型,检测再植后1-3天环氧合酶-2表达和PGE2浓度。
  • 体外用PGE2和EP4激动剂L-902688刺激人牙周膜干细胞(hPDLSCs),评估活力、凋亡和细胞周期。
  • 进行RNA测序探索下游机制,并重分析单细胞RNA测序数据确定主要有效受体。
  • 在小鼠干预模型中给予SW033291(15-羟基前列腺素脱氢酶抑制剂)或L-902688。

主要发现

  • 小鼠再植后1-3天牙周膜内环氧合酶-2表达和PGE2浓度升高。
  • 单细胞RNA测序重分析提示EP4是PGE2的主要有效受体。
  • PGE2和EP4激动剂处理增强hPDLSCs的增殖和活力。
  • RNA测序鉴定TCIM为Wnt/β-catenin通路的正调控因子和关键下游靶点。
  • 敲低TCIM可消除PGE2的促增殖效应。

临床怎么用

  • 提示PGE2/EP4/TCIM轴可作为改善牙再植预后的药物干预靶点。
  • EP4激动剂或15-羟基前列腺素脱氢酶抑制剂在动物模型中显示改善再植结局的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tooth replantation is a clinical treatment commonly used for refractory periapical periodontitis, tooth avulsion, and autotransplantation. The condition of the periodontal ligament (PDL) is a prognostic factor that affects replantation outcomes. Various studies have been devoted to improving the repair of the PDL after replantation to improve the prognosis. Prostaglandin E2 (PGE2), an inflammatory mediator with critical effects involved in stem cell regulation as well as in tissue repair and regeneration, has been found to be increased after replantation. Thus, we hypothesized that the increased PGE2 in the PDL microenvironment may influence the viability of the PDL stem cells to affect PDL repair and improve replantation outcomes. We established a mouse model and found increased cyclooxygenase-2 expression and PGE2 concentrations within 1 to 3 d postreplantation. Human PDL stem cells (hPDLSCs) were stimulated with PGE2 and an EP4 agonist (L-902688) to assess viability, apoptosis, and cell cycle. Ribonucleic acid sequencing was performed to explore downstream mechanisms. The reanalysis of single-cell ribonucleic acid sequencing data suggested EP4 was the principal effective PGE2 receptor. PGE2 and EP4 agonist treatment enhanced the proliferation and viability of hPDLSCs. Ribonucleic acid sequencing identified transcriptional and immune response regulator (TCIM), a positive regulator of the Wnt/β-catenin signaling pathway, as a key downstream target. Knockdown of TCIM abrogated the proliferative effects of PGE2. In a mouse intervention model, the administration of SW033291 (a 15-hydroxyprostaglandin dehydrogenase inhibitor) or L-902688 significantly improved outcomes and increased TCIM expression in vivo. Our study demonstrates that PGE2 transiently increases in the PDL following replantation and enhances the proliferative capacity of hPDLSCs via EP4 activation, leading to the upregulation of TCIM and Wnt pathway activation. These findings offer mechanistic insight into periodontal repair and support the development of pharmaceutical strategies to improve replantation outcomes.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Wu W, Sun J, et al. PGE2 Regulates Periodontal Ligament Repair after Tooth Replantation. J Dent Res. 2026. PMID: 41673410. doi:10.1177/00220345251407594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。